The selected aptamers have very low or no toxicity for hepatic cells.
Now, it has been of increasing interest to develop the signaling aptamers with the capability of real-time detection of targets in a simple and rapid way.
Screening and characterization of aptamers of chronic myelognous leukemia K562 cells
Such proteins are called peptide aptamers and are used to find drug candidates.